ECSP972297A - HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE - Google Patents
HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATEInfo
- Publication number
- ECSP972297A ECSP972297A ECSP972297A ECSP972297A EC SP972297 A ECSP972297 A EC SP972297A EC SP972297 A ECSP972297 A EC SP972297A EC SP972297 A ECSP972297 A EC SP972297A
- Authority
- EC
- Ecuador
- Prior art keywords
- conjugates
- treatment
- prostate
- cancer
- helpful
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
- 201000001514 prostate carcinoma Diseases 0.000 title 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
El invento se refiere a: Se revelan los conjugados químicos que comprenden oligopéptidos, que tienen secuencias de aminoácidos que son selectivo y proteolíticamente separados mediante el antígeno libre especifico de próstata (AEP) y agentes citotóxicos conocidos. Tales conjugados son útiles en el tratamiento de cáncer prostático e hipertrofia prostática benigna (HPB):The invention relates to: Chemical conjugates comprising oligopeptides, having amino acid sequences that are selectively and proteolytically separated by prostate specific free antigen (AEP) and known cytotoxic agents, are disclosed. Such conjugates are useful in the treatment of prostate cancer and benign prostatic hypertrophy (BPH):
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972297 ECSP972297A (en) | 1997-10-29 | 1997-10-29 | HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972297 ECSP972297A (en) | 1997-10-29 | 1997-10-29 | HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972297A true ECSP972297A (en) | 1998-12-14 |
Family
ID=42043126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972297 ECSP972297A (en) | 1997-10-29 | 1997-10-29 | HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972297A (en) |
-
1997
- 1997-10-29 EC ECSP972297 patent/ECSP972297A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008907A1 (en) | HELPFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE | |
| DE69838177D1 (en) | ANDROGENSYNTHESEINHIBITOREN | |
| ATE256473T1 (en) | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | |
| TR199903331T2 (en) | Farnesil protein transferase inhibitors. | |
| DE69703294D1 (en) | COMPOSITIONS CONJUGATE CONTAINING CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE | |
| BR0115953A (en) | Phosphate Derivatives Complexes | |
| YU9404A (en) | Peptide-based multimeric targeted contrast agents | |
| ATE301196T1 (en) | VARIANTS OF HUMAN GROWTH HORMONE | |
| EA200000603A1 (en) | CONJUGATES THAT CAN BE USED WHEN TREATING PROSTATE CANCER | |
| ES2181006T3 (en) | USE OF AMIDAS OF PIRIDIL ALCANOS ACIDS, PIRIDIL ALKENS AND / OR PIRIDIL ALKINES IN THE TUMOR TREATMENT OR IN IMMUNOSUPPRESSION. | |
| BG101077A (en) | PEPTIDES | |
| DE60040981D1 (en) | TREATMENT WITH ANTI-ErbB2 ANTIBODIES | |
| NO20020348L (en) | Peptide acceptor ligation methods | |
| GB9717905D0 (en) | Lipid-containing compositions and uses thereof | |
| CL2003002786A1 (en) | LIOFILIZED COMPOSITION THAT INCLUDES I) AN EPOTILONE AND II) MANITOL OR A CYCLODEXTRINE AND LIOFILIZED COMPOSITION THAT INCLUDES THEM RECONSTITUTED WITH SOLVENT, USED AS A CYTOTOXIC IN TUMOR TREATMENT. | |
| DE60238435D1 (en) | TARGETED THROMBOSE THROUGH TISSUE FACTOR POLYPEPTIDES | |
| ATE349419T1 (en) | SPERMINE:PEPTIDE CONTAINING SURFACTANTS | |
| PA8453601A1 (en) | FARNESIL TRANSFERASE INHIBITORS COMBINED WITH HMG COA REDUCTASE INHIBITORS FOR CANCER TREATMENT | |
| BRPI0401912A (en) | Aminoxide-containing preparations and anionic tensions | |
| MXPA04005942A (en) | Syn3 compositions and methods. | |
| DE60230133D1 (en) | TOLUOLSULFONAMIDE-CONTAINING ANTITUMOROUS COMPOSITION AND METHOD FOR THE APPLICATION THEREOF | |
| TR200100387T2 (en) | Pesticide formulations containing alkoxylated amine neutralized aromatic sulfonic acid surfactants | |
| ECSP982763A (en) | USEFUL CONJUGATES IN THE TREATMENT OF CANCER OF PROSTATE | |
| GB2418985B (en) | Protein markers for human benign prostatic hyperplasia(BPH) | |
| TR199701613T1 (en) | Melatonin agonists for the treatment of benign prostatic hyperplasia. |